Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of XueBiJing in Sepsis
NCT03475732Completed
- Sponsor
- Southeast University
- Start
- Mar 2018
- Primary completion
- Jun 2019
- Modality
- PE (Plant Extract)
- Countries
- 1
01
Overview
Open-label, single-arm trial of xuebijing in sepsis, sponsored by Southeast University. Primary endpoint: Plasma concentrations of XueBiJing injection compounds at Day 5. Started Mar 2018; status: completed.
02
Drugs
xuebijing
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT03475732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03475732.